Max Robotics — Global Service Robot Directory + US Certification

About

Hideyasu Matsuyama is a leading urologic oncologist whose work centers on the surgical management of urologic cancers—particularly bladder and kidney malignancies—and the advancement of clinical practice standards. He made a defining contribution to the field as a key author of the Japanese Urological Association’s *Clinical Practice Guidelines for Bladder Cancer 2019 edition*, a seminal document that synthesizes evolving evidence to shape national treatment protocols and improve patient outcomes. This guideline paper has accumulated 37 citations, reflecting its authority and widespread use in clinical decision-making. Matsuyama is also recognized for his expertise in minimally invasive surgery, as demonstrated in his reports on robot‑assisted partial nephrectomy and radical prostatectomy. His case studies—such as the novel use of endoscopic laser treatment for urine leakage from an isolated calyx after partial nephrectomy—highlight his technical skill in managing rare, complex postoperative complications. Through his blend of guideline development and innovative surgical technique, Matsuyama has had a direct impact on both the standardization and the advancement of urologic cancer care in Japan.